**INTRODUCTION:** Bell's palsy (BP)---idiopathic dysfunction of the seventh cranial nerve---is the most common cause of peripheral facial weakness, accounting for 60%--75% of unilateral facial paralysis.^1^ The incidence in the United States is 20--43 cases per 100,000 person-years.^2,3^ It is self-limiting in 71%--86% of cases---although, which patients are high risk for recovery failure is unclear.^1--3^ Patients with persistent dysfunction or sequela are a common referral population to plastic surgery; however, it is difficult to know when to intervene. This study aimed to elucidate the natural history of BP and patient clinical course.

**METHODS:** This study was a retrospective chart review for January 2011 to December 2017. An institutional database was queried for charts with *International Statistical Classification of Disease*, *9th Edition* (ICD-9) 351.0 or ICD-*10th Edition* (ICD-10) G51.0. All resulted charts were reviewed. Subjects required a new diagnosis of BP for inclusion and were excluded if: ICD code was inappropriate; ICD code was historical; or facial paralysis was secondary to another cause. Disease characteristics (laterality, severity, etc), clinical course (presentation location, follow-up, etc), intervention/treatments, and disease course (resolution, etc) were tracked. Tracking occurred until subjects met 1 of 3 criteria: (1) lost to follow-up; (2) complete resolution without sequela; and (3) 2 years after diagnosis.

**RESULTS:** A total of 3,026 potential subjects resulted from the query. Of those, 2,120 were excluded (268 inappropriate code; 1,389 repeat code; 452 paralysis secondary to another cause) and 906 met inclusion criteria. For follow-up visits, 437 had zero and 771 had ≤3. Average age was 48 ± 20 years at diagnosis with the majority white (673) and non-Hispanic (835). Incidence increased with age: 461 subjects ≥50 years old. There was no difference in age or disease laterality. Most subjects presented to an emergency department (545). Per documentation, 550 subjects were stated to have complete facial paralysis but lacked documentation of total involvement. Forehead, eyelid, and mouth paralysis were most commonly noted. Changes in taste, sensation, or tearing were the most frequent associated symptoms. Treatment was generally steroid alone (444) or steroid plus antiviral (302). There were 174 complete resolutions, and 523 subjects had partial improvement in paralysis. The remaining subjects were lost to follow-up, or documentation regarding progress was terminated without clear resolution. For those patients who showed improvement in symptoms or complete resolution, 90% occurred by 107 ± 100 days. Dyskinesis was noted in 4 subjects and synkinesis in 2.

**CONCLUSIONS:** The high rate of non--follow-up and poor documentation make the natural history of BP difficult to fully elucidate. Nevertheless, it seems safe to begin intervention---with reasonable assurance of disease plateau---at 200 days postdiagnosis. Additionally, BP sequela seem either inconsistently recorded or improperly detected and consequently undertreated.
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